EUVIMEDEUVIMED entdecken
Open Access

Increased Pro-inflammatory Biomarkers and Cardiovascular Risk in Young Adults Living With Perinatal HIV in Thailand

Linda Aurpibul iD, Kulkanya Chokephaibulkit iD, Wipaporn Natalie Songtaweesin, Pradthana Ounchanum, Pope Kosalaraksa iD, Tavitiya Sudjaritruk iD, Supattra Rungmaitree, Surinda Kawichai, Pagakrong Lumbiganon, Tulathip Suwanlerk, Thanyawee Puthanakit iD, Thai PAPAYA study team

Journal of the Pediatric Infectious Diseases Society · 2025

DOI: 10.1093/jpids/piaf053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Linda Aurpibul und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: HIV Infections, Cardiovascular Diseases. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: ViiV Healthcare, U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We assessed levels of pro-inflammatory biomarkers as possible surrogate markers of cardiovascular disease (CVD) risk in Thai young adults with perinatally acquired HIV infection (YA-PHIV).

Methods

Serum samples and baseline data from YA-PHIV enrolled in a prospective cohort study from November 2020 to July 2021 at five tertiary care hospitals in Thailand were analyzed. We measured high-sensitivity C-reactive protein (hs-CRP), soluble CD163 (sCD163), and interleukin (IL)-18 levels. Data were analyzed using nonparametric methods.

Results

Among 347 YA-PHIV, 54% were female, the mean age was 21.7 ± 2.0 years, the median duration of antiretroviral treatment was 16.7 years (IQR 13.4-18.4), and 72 (21%) had virologic failure (HIV viral load >1000 copies/mL). The hs-CRP levels were <1.0 mg/L (low CVD risk) in 170 (49%), between 1.0-<3.0 (indicating intermediate CVD risk) in 88 (25%), and ≥3 mg/L (indicating high CVD risk) in 89 (26%). The median IL-18 level was 82.2 pg/mL (IQR 33.9-151.7), and sCD163 was 53.6 ng/mL (IQR 31.1-90.1). YA-PHIV with virologic failure had a significantly higher level for all three biomarker levels than those with virologic suppression. Increasing age was associated with hs-CRP >3 mg/L; males were more likely to have high levels of IL-18; no factors were associated with sCD163 level.

Conclusions

Increased pro-inflammatory biomarkers in YA-PHIV support the presence of ongoing inflammation, particularly in those with virologic failure. HIV care for YA-PHIV should focus on virologic control and modifiable metabolic risk factors. Active monitoring for cardiovascular manifestations in YA-PHIV risk is warranted as they age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsCardiovascular DiseasesHumansFemaleMaleThailandBiomarkersProspective StudiesYoung AdultCD163 AntigenC-Reactive ProteinAntigens, Differentiation, MyelomonocyticAdultInterleukin-18Receptors, Cell SurfaceInflammationAntigens, CDHeart Disease Risk FactorsAdolescentViral LoadRisk FactorsInfectious Disease Transmission, Vertical

Stichwörter der Autor:innen

Thailandcardiovascular riskperinatal HIVpro-inflammatory biomarkersvirologic failureyoung adults

Substanzen

BiomarkersCD163 AntigenC-Reactive ProteinAntigens, Differentiation, MyelomonocyticInterleukin-18Receptors, Cell SurfaceAntigens, CD

Autor:innen und Institutionen

  • Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Siriraj Institute of Clinical Research and Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Faculty of Medicine, School of Global Health, Chulalongkorn University, Bangkok, Thailand.
  • Department of Pediatrics, Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.

ORCID-Profile: Linda Aurpibul, Kulkanya Chokephaibulkit, Pope Kosalaraksa, Tavitiya Sudjaritruk, Thanyawee Puthanakit

Förderung

  • ViiV Healthcare
  • U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • NCI NIH HHS
  • NIMH NIH HHS
  • NIDA NIH HHS
  • NHLBI NIH HHS
  • NIAAA NIH HHS

Zitieren

APA

Aurpibul, L., Chokephaibulkit, K., Songtaweesin, W. N., Ounchanum, P., Kosalaraksa, P., Sudjaritruk, T., Rungmaitree, S., Kawichai, S., Lumbiganon, P., Suwanlerk, T., Puthanakit, T., & Thai PAPAYA study team (2025). Increased Pro-inflammatory Biomarkers and Cardiovascular Risk in Young Adults Living With Perinatal HIV in Thailand. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf053

Vancouver

Aurpibul L, Chokephaibulkit K, Songtaweesin WN, Ounchanum P, Kosalaraksa P, Sudjaritruk T, et al. Increased Pro-inflammatory Biomarkers and Cardiovascular Risk in Young Adults Living With Perinatal HIV in Thailand. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf053

BibTeX
@article{Aurpibul2025,
  author = {Aurpibul, Linda and Chokephaibulkit, Kulkanya and Songtaweesin, Wipaporn Natalie and Ounchanum, Pradthana and Kosalaraksa, Pope and Sudjaritruk, Tavitiya and Rungmaitree, Supattra and Kawichai, Surinda and Lumbiganon, Pagakrong and Suwanlerk, Tulathip and Puthanakit, Thanyawee and Thai PAPAYA study team, Thai PAPAYA study team},
  title = {Increased Pro-inflammatory Biomarkers and Cardiovascular Risk in Young Adults Living With Perinatal HIV in Thailand},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2025},
  doi = {10.1093/jpids/piaf053}
}
Kostenlos starten →